tiprankstipranks
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market
CSTL
Castle Biosciences
RESEARCH TOOLSreports
Want to see CSTL full AI Analyst Report?

Castle Biosciences (CSTL) Income Statement

456 Followers

Castle Biosciences Income Statement

Last quarter (Q4 2025), Castle Biosciences's total revenue was $87.01M, an increase of 0.81% from the same quarter last year. In Q4, Castle Biosciences's net income was $-2.33M. See Castle Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 344.23M$ 332.07M$ 219.79M$ 137.04M$ 94.08M
Gross Profit
$ 236.35M$ 271.86M$ 174.81M$ 105.03M$ 78.26M
Operating Expenses
$ 279.16M$ 263.19M$ 242.78M$ 177.88M$ 118.34M
Depreciation and Amortization
$ 40.77M$ 16.00M$ 12.33M$ 10.54M$ 3.41M
EBITDA
$ 11.34M$ 38.14M$ -45.02M$ -58.34M$ -36.60M
Operating Income
$ -42.81M$ 8.67M$ -67.98M$ -72.86M$ -40.08M
Other Income/Expenses
$ 13.30M$ 12.89M$ 10.61M$ 3.95M$ 67.00K
Pretax Income
$ -29.51M$ 21.56M$ -57.37M$ -68.90M$ -40.01M
Net Income
$ -24.16M$ 18.25M$ -57.47M$ -67.14M$ -31.29M
Per Share Metrics
Basic EPS
$ -0.83$ 0.66$ -2.14$ -2.58$ -1.24
Diluted EPS
$ -0.83$ 0.62$ -2.14$ -2.58$ -1.24
Weighted Average Shares Outstanding
 28.99M 27.78M 26.80M 26.05M 25.14M
Weighted Average Shares Outstanding (Diluted)
 28.99M 29.25M 26.80M 26.05M 25.14M
Currency in USD

Castle Biosciences Earnings and Revenue History